专题报道:肾病

维持性血液透析患者血清正五聚蛋白3、铁调素水平与营养状况的关系

  • 黄艳 ,
  • 段书众 ,
  • 王京 ,
  • 刘洁琼 ,
  • 马良燕 ,
  • 李硕 ,
  • 吴艳青 ,
  • 王新阳 ,
  • 贾兰芳 ,
  • 王景福
展开
  • 1.承德医学院附属医院肾脏内科 (河北 承德 067000 )
    3.承德医学院附属医院医用材料处 (河北 承德 067000 )
    4.承德医学院附属医院神经外科 (河北 承德 067000 )
    2.河北省泛血管病实验室 (河北 承德 067000 )

收稿日期: 2025-06-04

  网络出版日期: 2025-11-13

基金资助

河北省医学科学研究课题(20231382)

Correlation analysis of serum pentraxin 3 and hepcidin with nutritional status in maintenance hemodialysis patients

  • Yan HUANG ,
  • Shuzhong DUAN ,
  • Jing WANG ,
  • Jieqiong LIU ,
  • Liangyan MA ,
  • Shuo LI ,
  • Yanqing WU ,
  • Xinyang WANG ,
  • Lanfang JIA ,
  • Jingfu. WANG
Expand
  • *.Department of Nephrology,the Affiliated Hospital of Chengde Medical College,Chengde 067000,Hebei,China
    *.Hebei Key Laboratory of Panvascular Diseases,Chengde 067000,Hebei,China

Received date: 2025-06-04

  Online published: 2025-11-13

摘要

目的 了解维持性血液透析(MHD)患者营养状况,探讨分析MHD患者血清铁调素、正五聚蛋白3(PTX3)水平与营养状况的关系。 方法 选自承德医学院附属医院入组符合标准的MHD患者76例,依据主观综合营养评估(SGA)对患者营养状态进行评估,分为SGA-A、SGA-B、SGA-C三个等级。采用酶标抗体法检测血清PTX3、铁调素的水平。应用SPSS 进行统计学分析,采用单因素方差分析比较3个SGA等级组间临床指标差异,影响营养不良的因素分析采用二元logistic回归,其中SGA-B、SGA-C为营养不良(45例),SGA-A为营养良好,血清铁调素、PTX3对营养状况的评估价值分析采用ROC分析。 结果 76例MHD患者中,营养不良者45例患者,占59.2%。对3组间临床资料进行比较显示,营养不良组男性占比更低,年龄更大,血超敏C反应蛋白(hs-CRP)、PTX3、铁调素水平更高(P < 0.05),血白蛋白水平、肌酐、血磷水平更低(P < 0.05)。对SGA等级进行量化分析,Spearman相关性分析显示,hs-CRP、PTX3、铁调素均与SGA等级呈正相关(P < 0.05)。以“营养不良”为因变量进行logistic回归分析提示,血清hs-CRP水平高、PTX3水平高、铁调素水平高、年龄更大是MHD患者营养不良的危险因素,血磷水平高、血肌酐水平高是MHD患者营养不良的保护因素。进一步进行多因素logistic回归分析提示,血清PTX3水平高是MHD患者营养不良的独立危险因素(P = 0.032),血肌酐水平高是MHD患者营养不良呈的独立保护因素(P = 0.047)。ROC分析显示,血肌酐联合PTX3对MHD患者营养不良有较高的评估价值,曲线下面积为0.789(P < 0.001),约登指数0.488,敏感度为77.8%,特异度为71.0%。 结论 高水平的PTX3及铁调素、低水平的血肌酐为MHD患者营养不良的危险因素,其中血清PTX3水平高、血肌酐水平低为MHD患者营养不良的独立危险因素,且对MHD患者营养不良有较好的评估价值。

本文引用格式

黄艳 , 段书众 , 王京 , 刘洁琼 , 马良燕 , 李硕 , 吴艳青 , 王新阳 , 贾兰芳 , 王景福 . 维持性血液透析患者血清正五聚蛋白3、铁调素水平与营养状况的关系[J]. 实用医学杂志, 2025 , 41(21) : 3338 -3344 . DOI: 10.3969/j.issn.1006-5725.2025.21.006

Abstract

Objective To investigate the association between nutritional status and serum hepcidin and pentraxin 3 (PTX3) levels in patients undergoing maintenance hemodialysis (MHD). Methods A total of 76 patients with MHD who met the inclusion criteria were recruited from the hemodialysis center at the Affiliated Hospital of Chengde Medical University. Nutritional status was assessed using the Subjective Global Assessment (SGA), which categorizes patients into three grades: SGA?A, SGA?B, and SGA?C. Serum levels of PTX3 and hepcidin were measured by enzyme?linked immunosorbent assay (ELISA). Statistical analyses were conducted using SPSS software. One?way analysis of variance (ANOVA) was applied to compare differences across the three SGA groups. Logistic regression analysis was performed to identify influencing factors, and receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic value. Among the participants, 45 patients were classified as malnourished based on SGA?B and SGA?C scores, while those with SGA?A constituted the well?nourished control group. Results Among the 76 MHD patients, 59.2% were malnourished. We then compared clinical characteristics across the three groups. The results showed that the malnourished group was older and exhibited significantly higher levels of hs?CRP, PTX3, and hepcidin (P < 0.05), while serum albumin, creatinine, and phosphorus levels were significantly lower (P < 0.05). Pearson correlation analysis revealed positive correlations between SGA grades and hs?CRP, PTX3, and hepcidin levels (all P < 0.05). Logistic regression analysis with “malnutrition” as the dependent variable indicated that elevated hs?CRP, PTX3, and hepcidin levels, along with age and male gender, were associated with increased risk of malnutrition in MHD patients, whereas higher serum phosphorus and creatinine levels were protective factors. Further multivariate logistic regression analysis demonstrated that serum PTX3 level was an independent risk factor for malnutrition (P = 0.032), while higher creatinine level was an independent protective factor (P = 0.047). ROC curve analysis showed that the combination of serum PTX3 and creatinine levels had a high diagnostic value for identifying malnutrition in MHD patients, yielding an AUC of 0.789 (P < 0.001), a Youden index of 0.448, sensitivity of 77.8%, and specificity of 71.0%. Conclusions Elevated levels of PTX3 and hepcidin, along with reduced serum creatinine levels, are associated with an increased risk of malnutrition in patients undergoing MHD. Notably, elevated serum PTX3 and decreased serum creatinine independently predict malnutrition in this population and demonstrate high predictive value.

参考文献

[1] ZHANG L, ZHAO M H, ZUO L, et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report [J]. Kidney Int Suppl, 2020, 10(2): e97-e185. doi:10.1016/j.kisu.2020.09.001
[2] COHEN-HAGAI K, NACASCH N, STERNSCHUSS A, et al. Malnutrition and inflammation in hemodialysis patients: Comparative evaluation of neutrophil reactive oxygen formation [J]. Nutrition, 2020, 78: 110793. doi:10.1016/j.nut.2020.110793
[3] RAHMAN T, KHOR B H, SAHATHEVAN S, et al. Protein Energy Wasting in a Cohort of Maintenance Hemodialysis Patients in Dhaka, Bangladesh [J]. Nutrients, 2022, 14(7)1408. doi:10.3390/nu14071469
[4] KALANTAR-ZADEH K, KOPPLE J D, BLOCK G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients [J]. Am J Kidney Dis, 2001, 38(6): 1251-1263. doi:10.1053/ajkd.2001.29222
[5] 陈璐琳, 杨廷杰, 孙猛,等. 营养不良与冠状动脉炎症对冠心病患者预后的影响 [J]. 实用医学杂志, 2025, 41(7): 1010-1017.
[6] 母元梅, 赵佳圆, 张莹. C反应蛋白/白蛋白比值与维持性血液透析患者心血管事件风险的关系 [J]. 实用医学杂志, 2024, 40(1): 72-78.
[7] VALENTE M J, ROCHA S, COIMBRA S, et al. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality [J]. Mediators Inflamm, 2019, 2019: 3295725. doi:10.1155/2019/3295725
[8] DONI A, MANTOVANI A, BOTTAZZI B, et al. PTX3 Regulation of Inflammation, Hemostatic Response, Tissue Repair, and Resolution of Fibrosis Favors a Role in Limiting Idiopathic Pulmonary Fibrosis [J]. Front Immunol, 2021, 12: 676702. doi:10.3389/fimmu.2021.676702
[9] SUH S H, OH T R, CHOI H S, et al. Predictive Value of Serum Hepcidin Levels for the Risk of Incident End-Stage Kidney Disease in Patients with Chronic Kidney Disease: The KNOW-CKD [J]. Kidney Dis (Basel), 2024, 10(6): 492-503.
[10] ZOU L X, SUN L, HUA R X, et al. Serum Hepcidin-25 and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis [J]. Int J Gen Med, 2021, 14: 3153-3162. doi:10.2147/ijgm.s313777
[11] XU Y, WANG Y, HU H, et al. Relationship between serum hepcidin levels and cardiovascular disease in patients with maintenance hemodialysis [J]. Physiol Int, 2020, 107(4): 491-500. doi:10.1556/2060.2020.00040
[12] FENG T, XU Y, ZHENG J, et al. Prevalence of and risk factors for chronic kidney disease in ten metropolitan areas of China: A cross-sectional study using three kidney damage markers [J]. Ren Fail, 2023, 45(1): 2170243. doi:10.1080/0886022x.2023.2170243
[13] 董朝坤, 翁敏. 生物电阻抗相位角在维持性血液透析患者营养状况中的研究进展 [J]. 实用医学杂志, 2022, 38(9): 1157-1160.
[14] CARRERO J J, THOMAS F, NAGY K, et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism [J]. J Ren Nutr, 2018, 28(6): 380-392. doi:10.1053/j.jrn.2018.08.006
[15] MORAIS D M, TROMBIM I C, DE G ES C R, et al. The adductor pollicis muscle thickness is not associated with physical function, lean mass, and nutritional status in patients on maintenance hemodialysis [J]. Front Nutr, 2024, 11: 1502309. doi:10.3389/fnut.2024.1502309
[16] TUR K, G L A. Independent Association Between Malnutrition Inflammation Score and C Reactive Protein/Albumin Ratio in Hemodialysis Patients [J]. J Inflamm Res, 2024, 17: 9325-9333. doi:10.2147/jir.s477307
[17] TAKAHASHI H, INOUE K, SHIMIZU K, et al. Comparison of Nutritional Risk Scores for Predicting Mortality in Japanese Chronic Hemodialysis Patients [J]. J Ren Nutr, 2017, 27(3): 201-206. doi:10.1053/j.jrn.2016.12.005
[18] TOLEDO F R, ANTUNES A A, VANNINI F C D, et al. Validity of malnutrition scores for predicting mortality in chronic hemodialysis patients [J]. Int Urol Nephrol, 2013, 45(6): 1747-1752. doi:10.1007/s11255-013-0482-3
[19] 刘洁琼, 王景福. 老年维持性血液透析患者穿透素3与超敏C反应蛋白和营养不良的关系 [J]. 河北医科大学学报, 2019, 40(6): 654-657.
[20] ROCHA S, VALENTE M J, COIMBRA S, et al. Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis [J]. Sci Rep, 2021, 11(1): 14768. doi:10.1038/s41598-021-94075-x
[21] YILMAZ M I, SONMEZ A, ORTIZ A, et al. Soluble TWEAK and PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes [J]. Clin J Am Soc Nephrol, 2011, 6(4): 785-792. doi:10.2215/cjn.09231010
[22] TSAI H C, OU S M, WU C C, et al. Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients [J]. Am J Nephrol, 2022, 53(2/3): 148-156. doi:10.1159/000522049
[23] LI H, MALHOTRA S, KUMAR A. Nuclear factor-kappa B signaling in skeletal muscle atrophy [J]. J Mol Med (Berl), 2008, 86(10): 1113-1126. doi:10.1007/s00109-008-0373-8
[24] MIYAMOTO T, RASHID QURESHI A, HEIMB RGER O, et al. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease [J]. Clin J Am Soc Nephrol, 2011, 6(12): 2785-2791. doi:10.2215/cjn.02320311
[25] FOUQUE D, KALANTAR-ZADEH K, KOPPLE J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int, 2008, 73(4): 391-398. doi:10.1038/sj.ki.5002585
[26] ISOYAMA N, QURESHI A R, AVESANI C M, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients [J]. Clin J Am Soc Nephrol, 2014, 9(10): 1720-1728. doi:10.2215/cjn.10261013
[27] GANZ T. Systemic iron homeostasis [J]. Physiol Rev, 2013, 93(4): 1721-1741. doi:10.1152/physrev.00008.2013
[28] MALTANERI R E, CHAMORRO M E, GIONCO S E, et al. Erythropoietin enhances iron bioavailability in HepG2 cells by downregulating hepcidin through mTOR, C/EBPα and HIF-1α [J]. Biochim Biophys Acta Mol Cell Res, 2024, 1871(7): 119800. doi:10.1016/j.bbamcr.2024.119800
[29] 张妍, 周晓玲, 陈孟华. 终末期肾脏病患者血清中铁调素的水平变化及其与铁代谢的关系 [J]. 中国血液净化, 2011, 10(7): 371-375.
[30] MATSUOKA T, ABE M, KOBAYASHI H. Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction [J]. Int J Mol Sci, 2024, 25(7):3745. doi:10.3390/ijms25073745
[31] GANGAT N, WOLANSKYJ A P. Anemia of chronic disease [J]. Semin Hematol, 2013, 50(3): 232-238. doi:10.1053/j.seminhematol.2013.06.006
[32] CARRERO J J, STENVINKEL P, CUPPARI L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM) [J]. J Ren Nutr, 2013, 23(2): 77-90. doi:10.1053/j.jrn.2013.01.001
[33] LI Y, YANG Y, WANG J. Skeletal muscle mass and kidney function among Chinese older adults: A cross-sectional study [J]. Ren Fail, 2024, 46(2): 2377776. doi:10.1080/0886022x.2024.2377776
文章导航

/